GlaxoSmithKline is feeling the heat from the rapid growth in electronic cigarettes, with enthusiasm for the nicotine delivery devices dampening sales of the British drugmaker's patches and gum, its chief executive said.
Breaking News
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Stellantis Plans to Lay Off Unspecified Number of Workers at US Factories in Coming Months
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- Oracle CEO Reveals Plans to Relocate World Headquarters to Nashville, Citing the City’s Reputation as Well-Established Health Center
- Samsung to Implement Six-Day Work Week for Executives Slammed by Critics 'Not Effective'
